HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Obrenovitch, T. P. Search for Related Content PubMed PubMed Citation Articles by Obrenovitch, T. P.

Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia

Division of Pharmacology, School of Life Sciences, University of Bradford, Bradford, United Kingdom

Ischemic tolerance describes the adaptive biological response of cells and organs that is initiated by preconditioning (i.e., exposure to stressor of mild severity) and the associated period during which their resistance to ischemia is markedly increased. This topic is attracting much attention because preconditioning-induced ischemic tolerance is an effective experimental probe to understand how the brain protects itself. This review is focused on the molecular and related functional changes that are associated with, and may contribute to, brain ischemic tolerance. When the tolerant brain is subjected to ischemia, the resulting insult severity (i.e., residual blood flow, disruption of cellular transmembrane gradients) appears to be the same as in the naive brain, but the ensuing lesion is substantially reduced. This suggests that the adaptive changes in the tolerant brain may be primarily directed against postischemic and delayed processes that contribute to ischemic damage, but adaptive changes that are beneficial during the subsequent test insult cannot be ruled out. It has become clear that multiple effectors contribute to ischemic tolerance, including: 1) activation of fundamental cellular defense mechanisms such as antioxidant systems, heat shock proteins, and cell death/survival determinants; 2) responses at tissue level, especially reduced inflammatory responsiveness; and 3) a shift of the neuronal excitatory/inhibitory balance toward inhibition. Accordingly, an improved knowledge of preconditioning/ischemic tolerance should help us to identify neuroprotective strategies that are similar in nature to combination therapy, hence potentially capable of suppressing the multiple, parallel pathophysiological events that cause ischemic brain damage.

This article has been cited by other articles:

				B. K. Wacker, T. S. Park, and J. M. Gidday Hypoxic Preconditioning-Induced Cerebral Ischemic Tolerance: Role of Microvascular Sphingosine Kinase 2 Stroke, October 1, 2009; 40(10): 3342 - 3348. [Abstract] [Full Text] [PDF]

				Y. Guan, R. T. Worrell, T. A. Pritts, and M. H. Montrose Intestinal ischemia-reperfusion injury: reversible and irreversible damage imaged in vivo Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G187 - G196. [Abstract] [Full Text] [PDF]

				R. Meller The Role of the Ubiquitin Proteasome System in Ischemia and Ischemic Tolerance Neuroscientist, June 1, 2009; 15(3): 243 - 260. [Abstract] [PDF]

				G. Tezel and the Fourth ARVO/Pfizer Ophthalmics Research Instit The Role of Glia, Mitochondria, and the Immune System in Glaucoma Invest. Ophthalmol. Vis. Sci., March 1, 2009; 50(3): 1001 - 1012. [Full Text] [PDF]

				H. A. Quigley Can Diabetes Be Good for Glaucoma? Why Can't We Believe Our Own Eyes (or Data)? Arch Ophthalmol, February 1, 2009; 127(2): 227 - 229. [Full Text] [PDF]